Neratinib
3144A1-2206 / B1891017
Phase 3 small_molecule active
Quick answer
Neratinib for Breast Cancer is a Phase 3 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 8 ClinicalTrials.gov record(s).
Program details
- Company
- PUMA BIOTECHNOLOGY, INC.
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active